BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 14508394)

  • 21. Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently.
    Bradley KJ; Wass JA; Turner HE
    Clin Endocrinol (Oxf); 2003 Jan; 58(1):59-64. PubMed ID: 12519413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silent Crooke's cell corticotroph adenoma of the pituitary gland presenting as delayed puberty.
    Giri D; Roncaroli F; Sinha A; Didi M; Senniappan S
    Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28458905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silent corticotroph adenomas: further clinical and pathological observations.
    Lopez JA; Kleinschmidt-Demasters Bk Bk; Sze CI; Woodmansee WW; Lillehei KO
    Hum Pathol; 2004 Sep; 35(9):1137-47. PubMed ID: 15343517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathology and pathogenesis of pituitary corticotroph adenoma].
    Trouillas J
    Neurochirurgie; 2002 May; 48(2-3 Pt 2):149-62. PubMed ID: 12058122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cushing's disease. Selective trans-sphenoidal resection of pituitary microadenomas.
    Tyrrell JB; Brooks RM; Fitzgerald PA; Cofoid PB; Forsham PH; Wilson CB
    N Engl J Med; 1978 Apr; 298(14):753-8. PubMed ID: 203853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pathology of Cushing's disease.
    Kovacs K
    J Steroid Biochem Mol Biol; 1993 Apr; 45(1-3):179-82. PubMed ID: 8481343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remission of pituitary-dependent Cushing's disease after removal of nonneoplastyic pituitary gland.
    Taylor HC; Velasco ME; Brodkey JS
    Arch Intern Med; 1980 Oct; 140(10):1366-8. PubMed ID: 6252859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Corticotroph adenoma].
    Guignat L; Assie G; Bertagna X; Bertherat J
    Presse Med; 2009 Jan; 38(1):125-32. PubMed ID: 19041214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathology of the pituitary.
    Doniach I
    Clin Endocrinol Metab; 1985 Nov; 14(4):765-89. PubMed ID: 3002676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary pathology in Cushing's disease.
    Saeger W; Geisler F; Lüdecke DK
    Pathol Res Pract; 1988 Sep; 183(5):592-5. PubMed ID: 3237549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease.
    Rak B; Maksymowicz M; Pękul M; Zieliński G
    Front Endocrinol (Lausanne); 2021; 12():672178. PubMed ID: 34135861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silent necrosis of a pituitary corticotroph adenoma revealed by timely magnetic resonance imaging: a cause of spontaneous remission of Cushing's disease.
    Le Nestour E; Abécassis JP; Bertagna X; Bonnin A; Luton JP
    Eur J Endocrinol; 1994 May; 130(5):469-71. PubMed ID: 8180674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
    Yap LB; Turner HE; Adams CB; Wass JA
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Corticotroph microadenomas of the pituitary stalk. Diagnostic and therapeutic difficulties].
    Jouanneau E; Perrin G; Trouillas J
    Neurochirurgie; 2002 May; 48(2-3 Pt 2):215-22. PubMed ID: 12058126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlates of long-term hypocortisolism after transsphenoidal microsurgery for Cushing's disease.
    Flitsch J; Lüdecke DK; Knappe UJ; Saeger W
    Exp Clin Endocrinol Diabetes; 1999; 107(3):183-9. PubMed ID: 10376443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features of silent corticotroph adenomas.
    Alahmadi H; Lee D; Wilson JR; Hayhurst C; Mete O; Gentili F; Asa SL; Zadeh G
    Acta Neurochir (Wien); 2012 Aug; 154(8):1493-8. PubMed ID: 22619024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metyrapone pre-treated inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    Cuneo RC; Lee W; Harper J; Mitchell K; Ward G; Atkinson RL; Salkield I; Cameron DP
    Clin Endocrinol (Oxf); 1997 May; 46(5):607-18. PubMed ID: 9231057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease.
    Hayashi K; Inoshita N; Kawaguchi K; Ibrahim Ardisasmita A; Suzuki H; Fukuhara N; Okada M; Nishioka H; Takeuchi Y; Komada M; Takeshita A; Yamada S
    Eur J Endocrinol; 2016 Feb; 174(2):213-26. PubMed ID: 26578638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ubiquitin immunoreactivity in corticotrophs following glucocorticoid treatment and in pituitary adenomas.
    Marin F; Cheng Z; Kovacs K
    Arch Pathol Lab Med; 1993 Mar; 117(3):254-8. PubMed ID: 8382913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission.
    Rees DA; Hanna FW; Davies JS; Mills RG; Vafidis J; Scanlon MF
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):541-51. PubMed ID: 11966748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.